Drug establishment licences and COVID-19 (English, HTML)
View metadata and access the original English HTML file: Drug establishment licences and COVID-19.
- Format
- HTML
- Access
- file-only
- Publisher-reported update
- 2020-08-28
All Canadian drug establishments must have a drug establishment licence to fabricate, package/label, distribute, import, wholesale or test a drug as required under Part C, Division 1A of the Food and Drug Regulations.
Data overview
- Formats
- HTML
- File languages
- English
- Available actions
- Access original file